Iams W, Beckermann KE, Neff AT, Mayer IA, Abramson VG
Med Oncol. 2013 30 (2)
· PMCID: PMC3774143
Chemotherapy-induced thrombotic microangiopathy is a severe illness that has occurred in a small number of patients treated with carboplatin and combination of docetaxel and trastuzumab chemotherapy. We describe herein the case of a patient with stage IIB breast cancer who developed thrombotic microangiopathy after five cycles of carboplatin, docetaxel, and trastuzumab.
MeSH Terms (13)Antibodies, Monoclonal, Humanized Antineoplastic Combined Chemotherapy Protocols Breast Neoplasms Carboplatin Chemotherapy, Adjuvant Docetaxel Female Humans Middle Aged Receptor, ErbB-2 Taxoids Thrombotic Microangiopathies Trastuzumab